James Linder
| Dr. James Linder | |
|---|---|
| Born |
October 21, 1954 Omaha, NE |
| Residence | Omaha, NE |
| Alma mater |
B.S., Iowa State University, 1976 M.D., cum laude, UNMC, 1980 Residency, Duke, UNMC |
| Occupation | Pathologist, Business Executive |
| Spouse(s) | Karen Linder |
| Children | 4 sons, 2 daughters |
Dr. James “Jim” Linder, MD, (born 1954) a noted author, academic and business leader, is an American authority on university research commercialization. [1] He serves as president of the University Technology Development Corp and Chief Strategist for the University of Nebraska System. He is also a professor of pathology and microbiology at the University of Nebraska Medical Center.
Early life
A native to Omaha, Linder earned his B.S. degree in biochemistry and microbiology from Iowa State University in 1976, and his M.D. degree, with distinction, from the University of Nebraska Medical Center in 1980. He completed his residency training in pathology at Duke University Medical Center and UNMC.
Current work
Linder and his wife, Karen Linder, are founders and managing directors of Linseed Capital, LLC, which invests in early stage companies.[2]
He serves on editorial boards of several medical journals, and is a former president of the American Society for Clinical Pathology.[3] From 1995 to 2007 he was affiliated with Cytyc Corporation, a Massachusetts-based medical company dedicated to women's health. In 2009 he became founding chief medical officer for Constitution Medical Investors. Their company was acquired by the Roche Diagnostics [4] in 2013 where he continues as a Chief Medical Officer, developing a hematology analyzer. [5]
He is a frequent guest lecturer, and has written five textbooks and more than 130 professional articles.[6]
He serves on several editorial boards, including the American Journal of Clinical Pathology[7] and Modern Pathology.[8]
He is a member and has served in leadership positions with many medical organizations, and a member of the Foundation Board of the U.S.-Canadian division of the International Academy of Pathology.[9]
He holds several patents, and his academic interests include the application of technology in medical diagnostics, including immunochemistry, molecular diagnostics, computer-aided instruction, digital imaging in pathology, and the use of automated techniques in cytopathology and hematology.
Other career highlights
Linder served as interim president of the University of Nebraska system from May, 2014 until April 2015.[10] He has served on the UNMC faculty since 1983 when he joined the Pathology and Microbiology Department. In 1986, he was named associate professor, and in 1989 was named professor. He has held numerous administrative positions at UNMC, including Vice Chairman of Pathology and Microbiology, Director of Surgical Pathology, Director of Cytopathology, Associate Dean for Academic Affairs and Interim Dean of Medicine. He was Associate Vice Chancellor for Research from 2005-2009, and was responsible for developing clinical research and intellectual property programs at UNMC.[11] He also served as visiting professor at the Peter Kiewit Institute.
In January 2007, UNMC's intellectual property office merged with UNeMed, and Linder was appointed president of the expanded operation.[12]
With Cytyc Corporation, a women's health company located in Marlborough, Mass., he served as medical director or Chief Medical Officer from 1995-07.[13] A main area of interest was improving Pap testing.
From 1998-99, he was president of the American Society of Clinical Pathologists.
Awards, honors, community service
Linder has been accorded many professional honors and awards. In 2015, recognizing his accomplishments in laboratory medicine and technology transfer, he was inducted as a Fellow of the National Academy of Inventors[14] In 2014 he and Karen Linder received the Entrepreneurial Leadership Award. [15] In 2013 Linseed Capital was recognized as Investor of the Year in the Silicon Prairie [16] In 2005, he was presented with the American Society of Clinical Pathologists "Israel Davidsohn Award for Distinguished Service".
From 1999-2001, he served on the board of directors of the Omaha Children’s Museum, and has served as chairman of the board of KANEKO, an organization devoted to fostering creativity in design and entrepreneurship.[17] He also is a regional board member of the Pipeline Entrepreneurship Program.[18] He also serves on the boards of the Nebraska Advanced Manufacturing Council, and the University of Nebraska Foundation.
Personal and family
Linder is married to Karen Linder SCT(ASCP), author of The Women of Berkshire Hathaway.[19]
References
- ↑ Association of Academic Health Centers, technology transfer conference, June 14, 2007
- ↑ Linseed Capital website
- ↑ Pathology Today, July 2005, page 8
- ↑ Roche Press Release
- ↑ Roche Diagnostics Hematology website
- ↑ UNMC website, list of Dr. J. Linder publications
- ↑ American Journal of Clinical Pathology, editorial board
- ↑ Modern Pathology, editorial board
- ↑ USCAP Foundation
- ↑ Lincoln Journal Star, March 21, 2014
- ↑ UNeMed news release, September 6, 2005
- ↑ UNMC news, January 9, 2007
- ↑ Cytyc Corp., news release, September 29, 2005
- ↑
- ↑ Nebraskaentrepreneurship news release
- ↑ Siliconprairie News
- ↑ KANEKO Open Space for your mind, Omaha
- ↑ Omaha.com, January 20, 2013
- ↑ Wordpress website
| Preceded by Dr. Philip Barney, M.D. |
President of American Society for Clinical Pathology 1998–1999 |
Succeeded by Dr. Stebbins Chandor, M.D. |
|
| ||||||||||